ResMed net profit under GAAP for 3 months 2021 amounted to $178.372 million, an increase of 48.5% compared to $120.148 million in the previous year. Revenue increased 10.4% to $751.944 million, against $681.056 million in the previous year.
ResMed net profit under GAAP for 3 months 2021 amounted to $178.372 million, an increase of 48.5% compared to $120.148 million in the previous year. Revenue increased 10.4% to $751.944 million, against $681.056 million in the previous year. 
investors.resmed.com
English (US) 